Viewing Study NCT06468033

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-06-06 @ 4:15 PM
Study NCT ID: NCT06468033
Status: RECRUITING
Last Update Posted: 2025-08-13
First Post: 2024-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Sponsor: PharmaEssentia
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloproliferative Neoplasm View
None Primary Myelofibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None P1101 View
None Primary Myelofibrosis View
None PMF View
None Ropeginterferon View
None PharmaEssentia View
None Myeloproliferative neoplasms View
None MPN View
None Pre-fibrotic View
None Low or Intermediate-1 Risk View